
Johann Gudjonsson
Program Director, M-ISAD and Program Associate, Internal Medicine · University of Michigan
Credentials: · · · ·
History
PresentM-ISAD and Program Associate, Internal Medicine · University of Michigan
Present
Present
1999–2002- 1998–1999
Preliminary or Transitional Year
- 1994–1998
Doctor of Medicine
Research
Review · The Lancet · 2021 · 1,948 citations
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways
Nature Genetics · 2009 · 1,175 citations
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Systematic review or meta-analysis · Nature Genetics · 2012 · 825 citations

111 papers

72 papers · 15 as a resident
- JE
69 papers
- JV
51 papers

45 papers · 16 as a resident

41 papers · 2 as a fellow

30 papers

25 papers
Grants
- 2024–2031
University of Michigan MHWFAC CoFar CMC Center Application
National Institute of Allergy and Infectious Diseases · U01
PI · $1.1M · University of Michigan at Ann Arbor
- 2025–2030
Integrated Program for Cutaneous Immune-Stromal Interactions in SLE (IPCISS)
National Institute of Allergy and Infectious Diseases · P01
PI · $3.1M · University of Michigan at Ann Arbor
- 2025–2030
Immune Cell Contributions to Inflammatory Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
PI · $1.4M · Vanderbilt University Medical Center
- 2019–2029
University of Michigan Skin Biology and Diseases Resource-Based Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Contact PI · $5.9M · University of Michigan at Ann Arbor
Clinical trials
- 2025–2028
Lebrikizumab in Moderate-to-severe Atopic Dermatitis
Principal investigator · Active not recruiting · Phase 4
Johann E Gudjonsson MD PhD
- 2023–2027
Ethnic Differences in Mechanisms of Action of Dupilumab
Principal investigator · Recruiting · Phase 4
University of Michigan
- 2017–2018
Skin Tape Harvesting for Transcriptomics Analysis
Principal investigator · Completed
University of Michigan
- 2016–2020
The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Principal investigator · Completed · Phase 2
University of Michigan


